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IMPACT OF PTSD ON HCV/HIV RISK-REDUCTION INTERVENTIONS AMONG 
INCARCERATED DRUG-USING WOMEN IN RURAL APPALACHIA 
 
          Justice-involved women in rural Appalachian Kentucky are a particularly 
vulnerable group in need of targeted risk-reduction interventions for hepatitis C virus 
(HCV) and human immunodeficiency virus (HIV). Compared to women in the general 
U.S. population, justice-involved women in rural Appalachia report dramatically higher 
rates of HCV/HIV risk behaviors (e.g., injection drug use and risky sex), interpersonal 
violence (IV; e.g., physical, sexual, or emotional abuse), and posttraumatic stress disorder 
(PTSD). IV and PTSD may exacerbate rural Appalachian women’s risk for contracting 
and transmitting HIV/HCV, indicating a need to approach HCV/HIV risk-reduction 
interventions from a trauma-informed perspective.  
 
Brief motivational interviewing and psychoeducation interventions have both 
demonstrated efficacy in decreasing HCV/HIV risk behaviors among incarcerated 
women, including those with IV histories. Yet, few studies have considered the impact of 
PTSD on the effectiveness of these interventions. Therefore, this study aimed to examine 
the impact of PTSD on the effectiveness of HCV/HIV risk-reduction interventions 
administered to incarcerated rural Appalachian women with IV histories.  
 
Participants included a sample of 320 IV-exposed women who were enrolled in 
the Women’s Intervention to Stop HIV and HCV study. Women were randomized to 
receive an enhanced motivational interviewing-based HCV/HIV intervention or a 
standard HCV/HIV psychoeducational intervention while they were incarcerated. 
Women were then followed at 3, 6, and 12 months after being released into the 
community. 
 
Our findings indicate women’s change in HCV/HIV risk behavior after being 
released from jail did not differ based on whether they received a brief psychoeducation 
alone or enhance with motivational interviewing while incarcerated. Moreover, PTSD 
symptoms were not associated with women’s change in injection drug or sexual risk 
behavior after community re-entry. PTSD symptoms trended toward decreasing more 
during re-entry for women who received a motivational-interviewing enhanced 
intervention compared to women who received psychoeducation alone, although this 
     
 
should be interpreted with caution. An unexpected finding was that anxiety and 
depressive symptoms prior to and during incarceration were associated with different 
trajectories of change in sexual, but not injection drug, risk behavior post-release.  
 
Results from this study address the call for evidence-based HCV/HIV 
interventions to be evaluated through a trauma-informed perspective and can inform 
targeted prevention and intervention efforts aimed at reducing HCV/HIV risk behaviors 
among rural Appalachian women. 
 
KEYWORDS: hepatitis c virus, human immunodeficiency virus, posttraumatic stress 
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CHAPTER 1.  INTRODUCTION
1.1 Background 
Reducing the spread of hepatitis C virus (HCV) and human immunodeficiency virus 
(HIV) in rural Appalachian Kentucky (KY) is an urgent public health priority. Out of every 
100,000 Kentuckians, currently 1,250 live with HCV and 196 live with HIV (AIDSVu, 
n.d.; HepVu, n.d.). Despite national and state-level public health initiatives aimed at
reducing the contraction and transmission of HCV and HIV in KY, new HCV diagnoses 
increased by 160% in the past decade while diagnoses of HIV stagnated (Northern 
Kentucky Health Department, 2017; Kentucky Department for Public Health, 2019). From 
2008-2015, KY had the highest rate of new HCV infections in the nation (Kentucky 
Department for Public Health, 2017). Fifty-four counties in KY’s Appalachian region are 
either at risk for or are currently experiencing an HCV or HIV outbreak, which accounts 
for 24.5% of all at-risk counties nationwide despite representing only 1.7% of total counties 
in the U.S. (Van Handel et al., 2016). The high rates of injection opioid and other drug use 
in rural Appalachian KY increases these communities’ vulnerability to the rapid spread of 
HCV and HIV (Moody et al., 2017; Zibbell et al., 2015).  
Justice-involved women in rural Appalachian KY are a unique and particularly 
vulnerable group in need of targeted interventions aimed at reducing the spread of HCV 
and HIV. Both injection drug use and sexual activity are established risk factors for HIV 
(Moody et al., 2017; Perlman et al., 2015; Zibbell et al., 2015). Among KY women newly 
diagnosed with HIV, one-third report injection drug use and two-thirds report heterosexual 
contact as the route of transmission (AIDSVu, n.d.). Injection drug use is also a risk factor 
for HCV, yet the role of sexual activity in the spread of HCV is less clear. Although the 
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risk of HCV transmission between members of monogamous heterosexual couples is low, 
HCV risk increases for women who engage in sexual risk behaviors (e.g., sex with multiple 
partners, sex under the influence of alcohol and/or drugs, sex in exchange for drugs and/or 
money, sex with high-risk partners) and for women who are co-infected with HIV or other 
sexually transmitted infections (Tohme & Holmberg, 2010). Compared to women in the 
general U.S. population, rural Appalachian women involved with the criminal justice 
system report dramatically higher rates of recent injection drug use (2% vs. 60%) and 
sexual risk behaviors (4% vs. 80%; Lansky et al., 2014; Staton et al., 2017, 2018a, 2018b, 
2018c; Women’s Health USA, 2012), which exemplifies their need for targeted HCV/HIV 
risk-reduction interventions.  
Periods of incarceration represent an underutilized intervention opportunity for rural 
Appalachian women—a group that represented the fastest-growing offender segment in 
the KY criminal justice system (Vera Institute of Justice [VIJ], 2019). Since 1980, the 
percent of women incarcerated in KY jails and prisons increased by 1,694% and 2,317%, 
respectively (VIJ, 2019). On a national scale, KY ranks second in the number of currently 
incarcerated women (The Sentencing Project, 2019). Although KY women are more likely 
to serve out their sentences in county jails rather than state prisons, county jails often 
provide less access to services, including healthcare and substance use treatment programs 
(Kentucky Legislative Research Commission, 2017). Correctional facilities in rural 
Appalachia house an unprecedented number of women at high risk for deleterious health 
outcomes, including HCV and HIV. Given that Appalachian women face multiple barriers 
to preventative care, including living in a remote geographical location, having limited 
access to health services, and lacking insurance coverage (Moody et al., 2017; Staton et al., 
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2001; Staton-Tindall et al., 2007; Stephens et al., 2017), periods of incarceration represent 
an essential intervention opportunity.  
Brief interventions administered to incarcerated women reduce HCV and HIV risk 
behaviors (Staton et al., 2017, 2018b). Two evidence-based approaches that have 
demonstrated efficacy in reducing HCV/HIV risk behaviors include NIDA Standard HIV 
Education (HIV-Ed) and Motivational Interviewing-based HIV Risk-reduction (HIV+MI). 
The HIV-Ed was developed through large, multisite cooperative agreement trials and aims 
to provide education on safe practices for injection drug use (e.g., identifying unsafe drug 
use, discussing needle and drug equipment cleaning strategies) and sexual activity (e.g., 
identifying unsafe sex, encouraging condom use and communication with partners; Coyle, 
1998). The HIV+MI intervention is grounded in the Transtheoretical Model of Health 
Behavior Change, which conceptualizes the process of behavior change as taking place in 
stages over time (e.g., precontemplation, contemplation, preparation, action, maintenance, 
termination; Prochaska et al., 2008; Prochaska & Velicer, 1997). Motivational interviewing 
is a validated therapeutic technique that facilitates the transition through the stages of 
change by incorporating patient-centered counseling techniques (e.g., reflective listening) 
and identifying discrepancies between life goals and current behavior (Miller & Rollnick, 
2002). Thus, the goal of HIV+MI is to reduce ambivalence and strengthen motivation 
toward behavior change and thereby reduce HCV/HIV risk behaviors. Comparative 
effectiveness studies show that both HIV+MI and HIV-Ed demonstrate considerable and 
comparable reductions in HCV/HIV risk behavior among women from rural Appalachia 
and women in urban settings (Staton et al., 2018b; Weir et al., 2009).  
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Research conducted in justice-involved rural Appalachian women highlights the 
need to adopt a trauma-informed perspective (Facer-Irwin et al., 2019; Levenson & Willis, 
2019), which recognizes the widespread impact of trauma and its effect on potential paths 
for recovery (Substance Abuse and Mental Health Services Administration [SAMHSA], 
2014). The lifetime prevalence of interpersonal violence (IV)—or physical, sexual, and 
emotional abuse (Rosenberg et al., 2006)—and posttraumatic stress disorder (PTSD; 
American Psychiatric Association [APA], 2013) are substantially elevated among 
incarcerated women in this region relative to women in the general U.S. population (IV: 
80% vs. 46%; PTSD: 67% vs. 10%; Iverson et al., 2013; Mitchell et al., 2012; Staton et al., 
2018b). Indeed, IV is associated with poorer perceived ability to negotiate safe sex and 
injection practices with partners (Mittal et al., 2013; Teitelman et al., 2008; Wagner et al., 
2009), and PTSD symptoms mediate the association between IV and HCV/HIV risk 
behaviors (Cavanaugh et al., 2010; Plotzker et al., 2007). Additionally, individuals with 
PTSD demonstrate poorer outcomes in substance use treatment (Kubiak, 2004; Read et al., 
2004), worse adherence to HIV antiretroviral therapy (Delahanty et al., 2004), and a need 
for enhanced monitoring while undergoing interferon-based therapies for HCV (Loftis et 
al., 2006). From a trauma-informed perspective, PTSD symptoms may exacerbate risk for 
HCV/HIV contraction and transmission in justice-involved rural Appalachian women. 
However, it is unknown to what extent brief HCV/HIV risk-reduction interventions are 
effective for justice-involved women with PTSD.  
Symptoms of PTSD affect a large proportion of justice-involved rural women and 
may interfere with current efforts to reduce HCV/HIV risk behaviors. One of the defining 
characteristics of PTSD is avoidance of trauma reminders (APA, 2013). Individuals with 
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PTSD may use substances and engage in risky sexual behavior to cope with or avoid their 
PTSD symptoms (McCauley et al., 2012; Weiss et al., 2013). Thus, rural Appalachian 
women with PTSD symptoms may not benefit from brief HCV/HIV risk-reduction 
interventions to the same extent as women without PTSD, as these risk behaviors may be 
inextricably linked with their ability to cope with trauma-related distress. Yet, preliminary 
findings suggest that motivational interviewing attenuates risk for developing PTSD 
following trauma exposure (Zatzick et al., 2004), enhances PTSD treatment outcomes 
(Randall & McNeil, 2017), and may reduce PTSD symptoms (Battaglia et al., 2016). Since 
motivational interviewing is founded upon facilitating behavior change, HCV/HIV risk-
reduction interventions that include a motivational interviewing component may offer 
more promise than standard psychoeducational interventions for IV-exposed incarcerated 
women with PTSD.  
1.2 Study Aims  
 This study addresses a critical gap in efforts to reduce injection drug use and risky 
sexual behavior among incarcerated women from rural Appalachia—a uniquely vulnerable 
and disadvantaged population at high risk for deleterious health outcomes—by examining 
HCV/HIV risk-reduction interventions through a trauma-informed perspective (Facer-
Irwin et al., 2019; Levenson & Willis, 2019; SAMHSA, 2014). More specifically, the 
present study addresses a significant gap in knowledge by (1) examining the effect of PTSD 
symptoms on evidence-based interventions that target HCV/HIV risk behavior 
administered to incarcerated women with IV histories and (2) evaluating the relationship 
between PTSD symptoms and HCV/HIV risk behavior during the community re-entry 
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period. The aims of the project were executed by examining secondary longitudinal data 
from the Women’s Intervention to Stop HCV/HIV study (WISH; NCT01840722; 
R01DA033866). The sample included 320 women with lifetime IV randomized to receive 
the NIDA Standard HIV Education alone (HIV-Ed) or the NIDA Standard HIV Education 
plus the Motivational Interviewing-based HIV Risk-reduction intervention (HIV+MI) 
while incarcerated. Participants were then followed at 3-, 6-, and 12-months following 
release from jail.  
 The first aim was to examine to what extent PTSD symptoms prior to incarceration 
predicted HCV/HIV risk behavior following community re-entry. We expected that higher 
PTSD symptoms prior to incarceration would predict higher rates of injection drug and 
sexual risk behavior post-release (Hypothesis 1a). We also hypothesized that women with 
higher PTSD symptoms prior to incarceration who received the enhanced HIV+MI 
intervention would report lower rates of injection drug use and risky sexual behavior post-
release relative to women with similar levels of PTSD in the HIV-Ed condition (Hypothesis 
1b).  
 The second aim of the study was to evaluate the extent to which reductions in PTSD 
symptoms following community re-entry predicted reductions in HCV/HIV risk behavior. 
We expected that women who received the HIV+MI intervention would demonstrate 
greater reductions in PTSD symptoms post-release relative to women in the HIV-Ed 
condition (Hypothesis 2a). We also hypothesized that PTSD symptom reduction would 
prospectively predict lower rates of injection drug use and risky sexual behavior 
(Hypothesis 2b). Findings from this study will inform targeted prevention and intervention 
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efforts aimed at reducing HCV/HIV risk behaviors among justice-involved rural 
Appalachian women with IV histories.  
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CHAPTER 2. METHODS 
2.1 Participants  
Participants included a subsample of women who were enrolled in the WISH study 
who reported a lifetime history of IV during the baseline interview. Women enrolled in the 
parent project were incarcerated in three rural Appalachian jails. Briefly, women were 
eligible for the study if they endorsed moderate need for a substance use intervention and 
reported at least one sexual risk behavior in the three months before incarceration (full 
eligibility criteria are described below). Women in the subsample were, on average, 33.0 
years of age (SD = 8.1), and almost all women reported their race as white (99.1%). Most 
women earned their high school diploma or GED (58.1%). One-third of women were 
married (31.3%) and most women (87.5%) had children. Demographic characteristics for 
the full sample are summarized elsewhere (Staton et al., 2018b).  
2.2 Measures 
Interviews were administered by trained personnel during incarceration (baseline) 
and at 3-, 6-, and 12-months following re-entry into the community (follow-up). 
However, it should be noted that not all measures were administered at every time point 
(see Table 2). 
A modified version of the Risk Behavioral Assessment (RBA; Wechsberg, 1998) 
was used to measure injection and sexual risk behaviors. The RBA is a brief interview that 
determines risk levels for contracting HIV and other infectious diseases by assessing a 
participant’s engagement in injection drug and sexual risk behaviors. Items on the modified 
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RBA were anchored to assess injection drug risk behavior in the year before incarceration 
(assessed at baseline) or since the last follow-up assessment. The modified RBA included 
the following items for injection drug risk behavior: (1) injected drugs; (2) used shared 
needle; (3) used shared works; (4) shared needles; (5) shared works; (6) shared injection 
equipment with sex partner; (7) did not always inject first. Items on the modified RBA 
measuring sexual risk behaviors include the following acts with the participant’s last main 
or casual partner: (1) did not use condom the entire time during last vaginal sex; (2) did 
not use condom the entire time during last anal sex; (3) used alcohol/drugs before or during 
last sex; (4) last partner has history of injecting drugs; (5) traded sex for drugs, money, etc. 
with last casual partner. In prior studies on individuals who use substances, the RBA 
demonstrated acceptable reliability and validity (Wechsberg et al., 2004).  
The Global Appraisal of Individual Needs (GAIN; Dennis et al., 2008) was used to 
assess PTSD and other comorbid psychiatric symptoms (i.e., anxiety and depression), as 
well as experiences of IV. The GAIN is a comprehensive interview that was originally 
developed for use by substance use treatment providers to make efficient mental health and 
substance use diagnoses and inform treatment placement and planning. Women were asked 
to what extent they experienced symptoms of PTSD, anxiety, and depression in the past 12 
months at baseline or since the last assessment at the 6- and 12-month follow-up. The 12-
item GAIN Traumatic Stress Scale (TSS) was used to assess PTSD symptoms. Scores on 
the TSS produce a total symptom count (0-12) with higher scores reflecting greater PTSD 
symptom severity. The total score can be dichotomized to reflect a possible diagnosis of 
PTSD (i.e., scores of >5 reflect “high traumatic stress” or possible PTSD). Given the 
notable comorbidity between PTSD, mood, and anxiety disorders (Price et al., 2019), the 
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12-item GAIN Anxiety and Fear Symptom Scale (AFSS) and the 9-item Depressive 
Symptoms Scale (DSS) were used to assess psychiatric conditions that are commonly 
comorbid with PTSD. The AFS and DSS produce symptom counts that range from 0-12 
and 0-9, respectively. The AFS and DSS scale scores were considered for inclusions as 
time-invariant covariates in the primary models for Hypothesis 1a and 1b, and time-varying 
covariates in models for Hypothesis 2a and 2b. Four dichotomous items (Yes/No) were 
used to assess women’s experiences of lifetime sexual, physical, or emotional abuse at 
baseline, and if they experienced these types of victimization since the last assessment at 
the 6- and 12-month follow-up. IV during the re-entry period was also considered for 
inclusion as a time-varying covariate in the models for Hypothesis 2a and 2b. Although the 
GAIN is not a formal diagnostic tool, it is a reliable and valid interview that measures IV 
experiences and produces provisional diagnoses of various psychiatric disorders (Dennis 
et al., 2008).  
At baseline, participants were also asked whether this was their first period of 
incarceration. Women reported subsequent incarcerations at the follow-up assessments; 
this variable was tested as a time-varying covariate in the primary models for Hypothesis 
1a, 1b, and 2b.   
2.3 Procedure  
 All study procedures were approved by the University of Kentucky’s Institutional 
Review Board and participants were protected under a federal Certificate of 
Confidentiality. Figure 1 displays an overview of study procedures and timeline relevant 
to the current project. Informed consent was obtained from all participants in the study.  
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2.3.1 Research Location and Random Selection 
This study used an established approach for data collection with incarcerated 
populations recommended by the National Institute of Justice (NIJ; 2003). Of the 27 jails 
located in rural Appalachian KY, participating jails were selected based on geographic 
location, having a daily census count above 50, and having no substance use treatment 
programs for inmates. Based on these criteria, three jails were selected for study inclusion: 
Perry County, Leslie County, and Laurel County. In total, there were approximately 65 
women incarcerated in these jails on a given day. From 2012-2015, recruitment in each of 
the three jails occurred once per month based on a randomization schedule that included 
all days of the week and all times of the day, consistent with recommendations from NIJ 
(2003). On each recruitment day, the targeted number of women inmates were randomly 
selected from the jail’s daily census record.  
 
2.3.2 Preliminary Screening  
 Screening and informed consent occurred in a private, confidential room in the jail 
and lasted approximately 20 minutes. During the informed consent procedure, women were 
reminded of the voluntary nature of the study. Screening measures evaluated need for 
substance use intervention and sexual risk behaviors in the past three months. Women were 
deemed eligible for study participation if they (1) endorsed at least moderate need for 
substance use intervention as indicated by a score of >4 for any substance measured by a 
modified version of the Alcohol, Smoking, and Substance Involvement Screening Test 
(NM-ASSIST; National Institute on Drug Abuse, 2009); (2) reported >1 self-reported 
sexual risk behavior (e.g., multiple sex partners, unprotected sex, sex under the influence 
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of alcohol or drugs) in the three months prior to incarceration as measured by three items 
from the RBA (Wechsberg, 1998); (3) demonstrated no evidence of cognitive impairment, 
active psychosis, or symptoms of physical substance withdrawal as measured by the GAIN 
(Dennis et al., 2008); (4) were incarcerated for at least one week following screening to 
complete the intervention; (5) lived in a rural Appalachian county prior to incarceration; 
and (6) reported a willingness to participate.  
 The initial recruitment phase for the WISH project occurred between 2012-2015. 
During this time, 900 incarcerated women were randomly selected for study screening, 688 
(76.4%) completed screening, 440 (48.9%) were eligible at screening, and 400 (44.4%) 
completed a baseline interview. Women enrolled in the WISH study were representative 
of the rural Appalachian region in KY in terms of race/ethnicity. Given the association 
between IV experiences and PTSD symptoms (Kilpatrick et al., 2017), a subsample of 
women with IV histories (n = 320) will be used to examine the impact of PTSD symptoms 
on HCV/HIV risk behavior. Demographic information and clinical characteristics of the 
subsample are presented in Table 1.  
 
2.3.3 Baseline Interview 
On the same day as the initial screening, those who met eligibility criteria 
completed a confidential, face-to-face interview. Trained research personnel administered 
the baseline interview, which lasted approximately two hours. Jail staff were allowed to 
monitor entry and exit of the private visiting room but were not permitted to be present in 
the room for the confidential interview. Prior to the interview, women were reminded of 
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 The aim of the parent project was to compare the effectiveness of two interventions 
aimed at reducing HCV/HIV risk behaviors among rural Appalachian justice-involved 
women (Staton et al., 2018b). Following the baseline interview, women had a 50/50 chance 
of being randomly assigned to one of two intervention conditions using Research 
Randomizer (www.randomizer.org). The NIDA Standard HIV Education (HIV-Ed) is a 
brief, single-session intervention that focuses on HIV education related to injection drug 
use (e.g., needle sharing, cleaning/bleaching injection equipment, disposal of hazardous 
waste material, stopping unsafe drug use, and benefits of drug treatment) and sexual 
practices (e.g., condom use, communication with sex partners, and stopping unsafe sexual 
practices) consistent with CDC guidelines. Women were also taught correct condom use 
and were given a list of local health and behavioral health services. The HIV-Ed occurred 
prior to HCV/HIV rapid testing and counseling. All study staff were certified HIV 
counselors by the Kentucky Department of Public Health.  
 Women randomized to receive the NIDA Standard HIV Education plus the 
Motivational Interviewing-based HIV Risk-reduction (HIV+MI) were provided the same 
single-session HIV Education during the baseline visit prior to HCV/HIV testing and 
counseling. Participants were then invited to participate in four brief motivational 
interviewing intervention sessions aimed at targeting motivation to change their injection 
drug use and risky sexual behavior. Motivational interviews were conducted prior to 
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release from jail. Consistent with prior research (Weir et al., 2009), the four motivational 
interviewing sessions focused on (1) enhancing women’s ability to identify risky drug use 
and sexual behaviors, (2) assessing women’s perceptions of risk and readiness to address 
risky drug use and sexual behavior, and (3) facilitating a stage-based discussion about drug 
use and sexual behavior change. The MI interventionist completed a 2-day training at the 
outset of the study and participated in on-going supervision throughout the study for quality 
control. Of the 166 women randomized to this condition, 111 (69.4%) completed all 4 
sessions, 9 (5.6%) completed 3 sessions, 22 (13.8%) completed 1-2 sessions, 18 (11.3%) 
did not complete any MI sessions. More than half (59%) of women screened positive for 
HCV antibodies and no women screened positive for HIV. 
2.3.5 Follow-up Data Collection 
Face-to-face follow-up interviews were conducted at 3-, 6-, and 12-months post-
release from jail at a location that was mutually agreed upon by the research staff and each 
study participant. Retention rates for the follow-up interviews ranged from 88-97%. 
2.4 Data Analytic Plan  
Chi-square tests and independent samples t-tests were used to compare whether 
women’s engagement in HCV/HIV risk behaviors prior to incarceration and levels of 
PTSD, anxiety, and depression in the year before baseline differed by intervention 
condition.  
Latent growth curve models (LGCMs) were used to examine to what extent PTSD 
symptoms prior to incarceration (i.e., baseline) predicted HCV/HIV risk behavior 
following community re-entry (Hypotheses 1a-1b) and to evaluate the extent to which 
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reductions in PTSD symptoms following community re-entry predicted reductions in 
HCV/HIV risk behavior (Hypotheses 2a-2b). This analytic approach is conceptualized in 
a structural equation analytic framework where initial states and change over time are 
depicted in the form of latent growth factors (e.g., intercept and slope; Duncan & Duncan, 
2009). The growth factors are latent in that they are not directly observed but are 
hypothesized to cause the observed outcomes over time. LCGMs are appropriate for 
longitudinal designs with repeated correlated observations and are robust to missing data, 
differing numbers of observations across participants, and unequally spaced time intervals 
(Curran et al., 2010). More specifically, LGCM can account for missing data using full 
information maximum likelihood (FIML) estimation. FIML estimates a likelihood function 
for each individual based on the variables that are present so that all available data are used.  
All LGCMs were conducted using Mplus Version 7.4 (Muthén & Muthén, 2015). 
Models were tested using a stepped approach. First, unconditional models—or models 
without predictors beyond the latent intercept and slope factors—were estimated to 
examine the best form of change in the outcome variable (HCV/HIV risk behavior, PTSD) 
from incarceration to community release. In other words, if participants changed on a given 
outcome during re-entry, the LGCM attempts to represent the best form or rate of change 
over time. Second, conditional models were tested with time-invariant and time-varying 
covariates that, based on prior research and theoretical rationale, were relevant to 
evaluating the primary hypotheses. TICs directly predict the latent growth factors, whereas 
TVCs directly predict the repeated measure of risk behavior while controlling for the 
influence of the latent growth factors (Curran et al., 2010). The deviance statistic (-2LL) 
was used to test the fit of nested models when adding time-invariant and time-varying 
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covariates (Schreiber et al., 2006). A significant p-value of the Chi-square deviance test 
indicates that the model with smaller deviance value fits better than the model with the 
larger deviance value, whereas a non-significant p-value indicates that the model with the 
larger deviance value fits better (Lee et al., 2018). The conditional LGCMs allow for 
estimation of between-person characteristics (interindividual differences) that predict 
individual variability (intraindividual variance) in the initial states and rate of change over 
time. Accounting for intraindividual variance in longitudinal designs decreases the 
probability of Type I errors (Gibbons et al., 2010). To aid in conceptualization of the 
LGCMs, Figure 2.2 depicts the associations among the latent growth factors of HCV/HIV 
risk behaviors, time invariant covariates, and time varying covariates.  
2.4.1 Hypothesis 1a and 1b 
After summing responses to the individual items on the RBA that measure injection 
drug and sexual risk behavior, a latent variable transformation was then used to transform 
the observed ordinal indicators from the summed scores into continuous latent variables 
(Lee et al., 2018). This transformation assumes that the observed ordinal indicators 
(summed scores) are discretized forms of a continuous underlying latent variable. Using a 
probit link function, the discretized continuum is defined by thresholds (i.e., cut points) 
that represent the distance between ordinal categories. Thresholds are calculated as the z-
scores associated with the proportion of the standard normal that is equal to the proportion 
of the sample endorsing a particular level on the ordinal scale. Thresholds are fixed to be 
equal across time points to meet the longitudinal threshold assumption and ensure 
measurement of the same construct over time (Masyn et al., 2013). In the LGCM with 
repeated ordinal observed variables, the initial level growth factor mean (intercept) reflects 
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the expected proportion of participants who engaged in the HCV/HIV risk behavior (i.e., 
their summed scores were greater than 0). The latent slope represents change in the 
propensity to engage in the risk behavior over time.  
 Using a stepped approach, unconditional models were first estimated to examine 
change in injection drug and sexual risk behavior in the year prior to incarceration 
(baseline) to community release (months 3, 6, and 12). The conditional LGCMs were then 
tested with time-invariant and time-varying covariates. Baseline PTSD symptoms were 
entered as a time-invariant covariate in order to evaluate to what extent higher symptoms 
were associated with a greater propensity for injection drug and sexual risk behavior post-
release (Hypothesis 1a). An interaction term between baseline PTSD symptoms and 
intervention condition was also entered as a time-invariant covariate to examine if women 
with higher PTSD symptoms prior to incarceration who received the enhanced HIV+MI 
intervention would report lower rates of injection drug use and risky sexual behavior post-
release relative to those women with higher PTSD symptoms in the HIV-Ed condition 
(Hypothesis 1b). Anxiety and depressive symptoms assessed at baseline were included as 
time-invariant covariates to evaluate whether PTSD symptoms at baseline predicted post-
release HCV/HIV risk behavior above-and-beyond other commonly comorbid psychiatric 
symptoms. HCV seropositive status was also tested as a time-invariant covariate to 
evaluate the effect of the interventions above-and-beyond women’s HCV status at baseline. 
Time-varying covariates included incarceration (months 3, 6, 12) and IV (months 6 and 
12) since both recidivism and re-victimization may impact the extent to which participants 
engage in post-release HCV/HIV risk behavior.  
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2.4.2 Hypothesis 2a and 2b 
The first step in the analyses for Hypothesis 2a—testing whether women who 
received the HIV+MI intervention would demonstrate greater reductions in PTSD 
symptoms post-release relative to women in the HIV-Ed condition—was to specify a 
measurement model and examine factorial invariance of PTSD symptoms over time. 
Briefly, testing measurement invariance is important so that changes in mean levels of the 
construct reflect actual changes in the construct, rather than in how the construct was 
measured (Little, 2013). The 12 items from the GAIN TSS were used as measured 
indicators of PTSD symptoms assessed at baseline, month 6, and month 12. The benefit of 
conducting a measurement model (rather than using a sum) is that this method accounts for 
measurement error and correlated residuals between measured indicators (Little, 2013). A 
mean- and variance-adjusted weighted least squares (WLSMV) estimation was used in the 
measurement model and the comparative fit index (CFI), Tucker-Lewis index (TLI), and 
root mean square error of approximation (RMSEA) were used to evaluate model fit. CFI 
and TLI Values of > .95 and RMSEA values of < .06 to .08 indicate acceptable model fit 
(Schreiber et al., 2006). Due to convergence issues, FIML (described above) was used 
when estimating conditional PTSD models during the re-entry period.  
The second step involved adding latent growth factors to the measurement model. 
The intercept mean and variance were fixed to 0. Since PTSD was only assessed at three 
time points (baseline, month 6, and month 12), a latent linear slope was used to estimate 
change in PTSD over time. After adding the latent growth factors, the third step was to 
conduct conditional models that included time-invariant and time-varying covariates. 
Intervention condition was included as a time-invariant covariate. Depression and anxiety 
19 
 
assessed at baseline, month 6, and month 12, as well as IV and incarceration assessed at 
months 6 and 12 were included as time-varying covariates to examine the effect of 
intervention condition above and beyond other factors that may impact PTSD symptoms 
during the re-entry period.  
To examine whether changes in PTSD prospectively predict HCV/HIV risk 
behaviors during the re-entry period (Hypothesis 2b), we calculated a difference score by 
subtracting the latent factor of PTSD at baseline from the latent factor of PTSD at month 
6 (negative scores indicate a decrease in symptoms between these time points). This 
difference score was then used to predict injection drug and sexual risk behavior at month 
12, while controlling for the latent factor score of PTSD symptoms at the same time point 
and including relevant time-invariant and time-varying covariates, as specified below. The 
structure of these models is similar to what has already been described for Hypothesis 1a 
and 1b, with the exception that the intercept was set to 0 at month 12, rather than at baseline.     
2.5 Sample Size Justification  
Since the current study is a secondary data analysis with a fixed sample size, a 
sensitivity analysis was performed to determine the smallest effect size that could be 
detected, referred to as the minimum detectable effect size (MDES). The power calculation 
was computed for the most stringent analytical model—the two-way interaction between 
intervention condition and PTSD presented in Aim 1. To calculate the MDES for the main 
effect of PTSD and the interaction between PTSD and intervention condition (HIV-
Ed/HIV+MI) on the slope of change over time, as specified in the first aim, a Monte Carlo 
simulation with 100,000 replications was performed. For Hypothesis 1a, a sample size of 
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320 women in which 70% had probable PTSD, 80% of the time a difference in slopes of B 
= 0.15 was detected at α = .05. This difference in slopes corresponds to a small-medium 
effect (Cohen, 1969). For Hypothesis 1b, where the interest is in the interaction between 
PTSD and intervention condition, 80% of the time a difference in slopes of B = .35 was 
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CHAPTER 3. RESULTS 
3.1 Descriptive Statistics  
The percentages of injection drug and sexual risk behavior and incarceration status, 
as well as mean psychiatric symptom scores measured at baseline and follow-up are 
reported in Table 3.1. Consistent with prior studies using the WISH sample (Staton et al., 
2018b), women’s engagement in injection drug and sexual risk behaviors in the year before 
incarceration did not significantly differ by intervention condition (injection drug risk 
behavior ps = .58 - .94; sexual risk behavior ps = .07 - .97). Women in the HIV+MI and 
HIV-Ed conditions reported similar rates of lifetime exposure to physical, sexual, and 
emotional abuse (ps = .07 - .74). Women’s PTSD (p = .06), anxiety (p = .44), and 
depressive symptoms (p = .36) at baseline also did not significantly differ by intervention 
condition. Overall, women’s engagement in HCV/HIV risk behaviors and their psychiatric 
symptoms decreased from pre-incarceration (baseline) to community re-entry (follow-up). 
Pearson correlations between PTSD, anxiety, and depressive symptoms at each time point 
are presented in Table 3.2. Except for the non-significant relations between PTSD at 
baseline and PTSD at month 6, PTSD at month 12, and anxiety at month 6, all other 
correlations between PTSD, anxiety, and depression were positively associated.  
3.2 Development of the LGCMs  
We compared unconditional models using latent linear and quadratic slopes to best 
estimate participants’ patterns of change in HCV/HIV risk behaviors over time (Hypothesis 
1a and 1b). In the models with a linear slope, factor loadings were set to 0, .5, 1, and 2 to 
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reflect change in 6-month increments and account for unequally spaced assessments. The 
quadratic slope models included the linear slope plus a quadratic slope term with factor 
loadings of 0, .25, 1, and 4. As shown in Table 3.3, models with linear and quadratic slopes 
demonstrated better fit than models with only linear slopes. Thus, models with linear and 
quadratic slopes were retained for use in further analyses. For the models examining PTSD 
change from baseline to month 6 as a predictor of HCV/HIV risk behavior at month 12 
(Hypothesis 2b), the factor loadings for the linear and quadratic slopes were re-coded to -
2, -1.5, -1, 0 and 4, 2.25, 1, 0 to set the intercept at the last assessment period.  
When specifying the measurement model for PTSD (Hypothesis 2a), we tested 
factorial invariance to evaluate whether the properties of the PTSD assessment were stable 
across time points (Elsworth et al., 2015). Compared to a model with configural invariance, 
imposing weak and strong invariance restrictions significantly worsened model fit (weak: 
χ2(22) = 38.22, p = .02; strong: χ2(24) = 196.85, p < .001). We retained the unrestricted model 
because it was a good fit to the data (χ2(637) = 1362.27, p < .001; RMSEA = .06; CFI/TLI = 
.98/.98) and the factor loadings of each indicator were consistent across time. We can 
interpret change in PTSD across time as actual change in the construct rather than how the 
construct was measured. Figure 3.1 displays the standardized parameter estimates from 
fitting the measurement model. Including the latent intercept and slope resulted in a model 
with good fit (χ2(614) = 668.09, p = .06; RMSEA = .02; CFI/TLI = .99/.99). 
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3.3 Primary Aims 
3.3.1 Aim 1: Examine to what extent PTSD symptoms prior to incarceration predict 
HCV/HIV risk behavior following community re-entry.  
3.3.1.1 Unconditional Model for Injection Drug Risk Behavior 
Results of the unconditional model are presented first to summarize the latent growth 
factors for injection drug risk behavior during the re-entry period. The model-implied 
observed proportions for each response category (0 to 7 injection risk behaviors) by time 
point are displayed in Figure 3.2. As shown in Table 3.4, the estimated intercept mean was 
significant indicating that more than 50% of women reported at least one injection drug 
risk behavior (i.e., fell above the first threshold). Propensity to engage in injection drug 
risk behavior significantly decreased from pre-incarceration across the re-entry period 
(negative linear slope) and this decrease slowed across time (positive quadratic slope). 
There was significant unexplained variance person-to-person in women’s propensity to 
engage in injection drug risk behavior prior to incarceration, as well as their trajectory of 
change in risk behavior during the re-entry period (positive linear and quadratic slope 
variances).  
 
3.3.1.2 Unconditional Model for Sexual Risk Behavior  
The model-implied observed proportions for each response category (0 to 5 
sexual risk behaviors) by time point are displayed in Figure 3.2. As shown in table 3.4, 
the estimated intercept mean was significant suggesting that more than 50% of women 
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reported at least one sexual risk behavior (i.e., fell above the first threshold). Propensity 
to engage in sexual risk behavior significantly decreased from pre-incarceration across 
the re-entry period (negative linear slope) and this decrease slowed across time (positive 
quadratic slope). There was significant unexplained variance person-to-person in 
women’s propensity to engage in sexual risk behavior prior to incarceration and their 
trajectory of change in risk behavior during the re-entry period (positive linear and 
quadratic slope variances).  
 
3.3.1.3 Conditional Models for Injection Drug and Sexual Risk 
Behavior  
In the conditional LGCMs for injection drug and sexual risk behavior, each time-
invariant and time-varying covariate was entered independently, and fit statistics were 
compared against the unconditional quadratic slope models (see Table 3.3). Model fit 
significantly worsened after adding HCV seropositive status at baseline as a time-invariant 
covariate, as well as both incarceration and IV experiences during the follow-up period as 
time-varying covariates. Thus, the final conditional models for Hypothesis 1a and 1b 
included the following time-invariant covariates: intervention condition; symptoms of 
PTSD, anxiety, and depression; and the interaction between intervention condition and 
PTSD symptoms (injection drug risk: -2LL = -1227.03; FP = 30; AIC = 2514.06; BIC = 
2627.11; sexual risk: -2LL = -1672.44; FP = 28; AIC = 3400.88; BIC = 3506.40). 
 Table 3.4 reports the parameter estimates for the conditional LGCMs estimating 
injection drug and sexual risk behavior during the re-entry period. For ease of visual 
interpretation, the probabilities depicted in Figures 3.3 through 3.6 represent 
dichotomized HCV/HIV risk behavior, where 0 = denied and 1 = endorsed. Figures 3.3 
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and 3.4 show the non-significant effect of intervention condition on change in injection 
drug and sexual risk behavior during re-entry. Although none of the time-invariant 
covariates were significantly associated with the growth factors in the model estimating 
injection drug risk behavior, anxiety and depression at baseline were related to sexual risk 
behavior. As shown in Figure 3.5, higher baseline levels of anxiety were associated with 
a greater propensity of engaging in sexual risk behavior at baseline (positive intercept 
coefficient) and a steeper decline in sexual risk behavior across the re-entry period 
(negative linear slope coefficient). Additionally, women with higher anxiety severity at 
baseline experienced a steeper reduction in sexual risk behavior soon after release from 
jail, whereas sexual risk behavior declined more steadily across the re-entry period 
among those with lower anxiety symptom severity (positive quadratic slope). The 
opposite pattern was found for depression (Figure 3.6): women with lower depression 
severity at baseline experienced a steeper reduction in sexual risk behavior soon after 
being released, whereas sexual risk-taking declined more steadily during re-entry for 
women with higher anxiety symptoms (negative quadratic slope). No other time-invariant 
covariates were significantly associated with the intercept or growth factors for sexual 
risk behavior. Neither anxiety (B = 0.07, SE = 0.04, p = .08), nor depression (B = -0.06, 
SE = 0.05, p = .23) were significantly associated with sexual risk behavior at month 12, 
suggesting the effect of anxiety and depression on sexual risk-taking may dissipate as 




3.3.2 Aim 2: Evaluate the extent to which reductions in PTSD symptoms following 
community re-entry predict reductions in HCV/HIV risk behavior.  
3.3.2.1 Unconditional and Conditional Models for PTSD  
After establishing good fit using WLSMV in the PTSD measurement model, FIML 
was used in the unconditional and conditional models estimating change in PTSD over 
time. In the unconditional model, PTSD symptoms significantly decreased (B = -1.50, SE 
= 0.25, p < .001). There was significant unexplained variance person-to-person in women’s 
rate of change in PTSD symptoms during the re-entry period (B = 2.23, SE = 0.74, p = 
.003).  
For the conditional LGCMs for PTSD, each time-invariant and time-varying 
covariate was entered independently, and fit statistics were compared against the 
unconditional linear slope model (see Table 3.5). Model fit significantly worsened after 
adding HCV seropositive status as a time-invariant covariate, as well as anxiety and 
depression, IV experiences, and incarceration status as time-varying covariates. Thus, the 
final conditional models for Hypothesis 2a only included the intervention condition as a 
time-invariant covariate (AIC = 6868.26; BIC = 6973.78). The effect of intervention 
condition significantly predicted the baseline centered intercept of PTSD (B = 0.88, SE = 
0.34, p = .01) which suggests that women in the HIV+MI condition had higher model 
estimated PTSD symptoms in the year prior to baseline compared to women in the HIV-
Ed condition. The effect of intervention condition on change in PTSD across the re-entry 
period approached significance (B = -0.66, SE = 0.34, p = .052). As depicted in Figure 3.7, 
women’s PTSD symptoms decreased -0.66 units in the HIV+MI condition than in the HIV-
Ed condition. Additional models were run with the intercept set at each follow-up 
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assessment, and results suggest women’s PTSD symptoms did not differ by intervention 
condition at month 6 (B = 0.37, SE = 0.31, p = .23) or month 12 (B = -0.12, SE = 0.41, p = 
.77).  
3.3.2.2 Conditional Model for Change in PTSD Predicting 
Change in HCV/HIV Risk Behavior 
When adding the difference in factor scores between baseline PTSD and month 6 
PTSD, as well as the factor score of PTSD at month 12, the model fit for both injection 
drug (-2LL, FP = -1883.22, 22; χ2(df) = 645.94 (7), p < .001) and sexual risk behavior (-
2LL, FP = -2333.20, 20; χ2(df) = 642.97 (7), p < .001) was significantly worse compared 
with the unconditional model. Change in the PTSD factor scores from baseline to month 6 
did not significantly predict injection drug (B = -0.14, SE = 0.09, p = .14) or sexual risk 
behavior (B = -0.06, SE = 0.08, p = .42) at month 12. However, higher PTSD factor scores 
at month 12 were positively associated with a greater propensity to engage in injection drug 
(B = 0.36, SE = 0.15, p = .02) and sexual risk behavior (B = .43, SE = 0.12, p < .001) at the 
same time point. The PTSD factor scores at month 12 were positively associated with the 
PTSD difference score (B = 0.06, SE = 0.03, p = .01) in both models. Additional time-
invariant and time-varying covariates were not added to the model, as this worsened model 
fit.  
 
Table 3.1 Sample Characteristic at Baseline and Follow-up by Intervention Condition 



















Incarceration (%)          
  First incarceration   7.0 8.5 5.5       
  Recent incarceration     19.5 17.9 31.7 21.9 43.0 33.0 
Injection Drug Risk Behavior (%)          
  Lifetime injection drug use 77.2 76.0 78.3       
  Injection drug use 61.3 61.7 60.8 18.8 18.5 22.5 25.2 18.5 24.5 
  Used shared needle  50.9 49.4 52.4 14.8 13.6 20.4 19.2 17.0 21.8 
  Used shared works 45.9 46.1 45.8 14.1 10.5 16.9 17.2 14.8 17.0 
  Shared needles 47.2 47.4 47.0 10.7 9.9 14.1 13.9 8.9 15.0 
  Shared works 44.4 44.2 44.6 10.7 9.9 14.1 13.2 8.9 13.6 
  Shared equipment with partner 40.6 41.6 39.8 8.7 7.4 12.0 9.3 8.9 11.6 
  Did not always inject first 37.8 38.3 37.3 1.3 0.6 12.7 12.6 8.1 15.0 
Sexual Risk Behavior (%)          
  Unprotected vaginal sex 89.7 89.6 89.8 59.7 54.3 67.6 62.3 65.2 61.9 
  Unprotected anal sex 11.6 14.9 8.4 4.7 1.9 2.8 2.6 2.2 2.0 
  Used alcohol/drugs before sex 84.4 83.8 84.9 26.8 21.6 32.4 23.2 31.9 29.3 
  Last sex partner injected drugs 57.8 59.7 56.0 36.2 33.3 38.7 32.5 39.3 36.1 




Table 3.1 (continued) Sample Characteristic at Baseline and Follow-up by Intervention Condition 
Note: HIV-Ed = NIDA Standard HIV Education; HIV+MI = Motivational Interviewing-based HIV Risk-reduction. 















Interpersonal Violence (%) 
 Sexual abuse 56.6 51.3 61.4 1.4 1.3 0.7 2.7 
 Physical abuse  85.0 89.0 94.0 9.2 6.0 8.9 5.4 
 Emotional abuse 91.6 85.1 84.9 14.1 12.6 16.3 13.6 
   Sexual, physical, emotional abuse 100.0 100.0 100.0 16.2 12.6 17.8 14.3 
Psychiatric Symptoms (M, [SD]) 
   Possible PTSD diagnosis (%)  69.7% 63.6% 75.3% 32.4% 41.7% 37.0% 31.3% 
 PTSD symptoms (range 0-12) 7.14 (4.74) 6.62 (4.96) 7.63 (4.48) 3.40 (4.61) 4.17 (4.61) 3.82 (4.46) 3.29 (4.54) 
 Anxiety symptoms (range 0-12) 5.58 (3.66) 5.42 (3.70) 5.73 (3.63) 2.00 (2.93) 2.35 (3.26) 1.98 (2.72) 1.88 (3.07) 
























BL PTSD          
M6 PTSD .02         
M12 PTSD .10     .29***        
BL Anxiety       .37*** .12* .23***       
M6 Anxiety .08      .45*** .31***     .17**      
M12 Anxiety      .16**      .26*** .60***      .22***   .42***     
BL Depression        .37***    .16** .25***      .74*** .19** .24***    
M6 Depression    .12*      .38*** .27*** .14*   .74*** .31*** .16**   
M12 Depression      .23**      .22*** .54***      .23***   .32*** .63***   .23*** .38***  
Note: BL = baseline; M6 = Month 6; M12 = Month 12.  







3.3 Deviance Tests for Unconditional and Conditional Injection Drug and Sexual Risk Behavior Models 
 Injection Drug Risk Behavior  Sexual Risk Behavior 
 -2LL, FP χ2(df), p  -2LL, FP χ2(df), p 
Slope      
Linear  -1282.94, 11   -1787.14, 9  
Quadratic  -1237.28, 15   46.66 (4), p < .001  -1690.23, 13  96.91 (4), p < .001 
Time-invariant covariates      
Intervention condition -1235.78, 18   1.50 (3), p = .68  -1689.08, 16   1.15 (3), p = .77 
PTSD -1230.39, 18   6.89 (3), p = .08  -1684.15, 16   6.08 (3), p = .11 
Anxiety and depression -1233.03, 21   4.25 (6), p = .64  -1682.46, 19   7.76 (6), p = .26 
HCV seropositive status -1433.49, 20 196.21 (5), p < .001  -1891.28, 18 201.06 (5), p < .001 
Time-varying covariates      
Incarceration -1657.70, 33 432.31 (18), p < .001  -2112.05, 34 421.82 (21), p < .001 
Interpersonal violence -1418.94, 28 181.66 (13), p < .001  -1874.23, 26 184.66 (13), p < .001 
Note: -2LL = loglikelihood; FP = free parameters; df = degrees of freedom. Nested model comparisons (chi-square deviance tests) were used to 






Table 3.4 Unconditional and Conditional Latent Growth Curve Model Estimates for the Effect of Baseline PTSD and Intervention 
Condition on Injection Drug and Sexual Risk Behavior 
 Injection Drug Risk Behavior  Sexual Risk Behavior 
 Unconditional LGCM  Conditional LGCM  Unconditional LGCM Conditional LGCM  
Means and Variances       
   I mean     0.37 (0.09), p < .001   0.03 (0.21), p = .90   1.94 (0.14), p < .001 1.66 (0.24), p <.001 
   I variance     0.81 (0.42), p = .055   0.44 (0.33), p = .18   0.82 (0.26), p = .002 0.74 (0.25), p = .003 
   LS mean    -4.17 (0.55), p < .001 -4.93 (1.40), p < .001  -3.11 (0.27), p < .001    -3.29 (0.63), p <.001 
   LS variance  10.18 (3.73), p = .006  8.14 (4.13), p = .049   5.69 (1.82), p = .002 5.34 (1.76), p = .002 
   QS mean   1.56 (0.27), p < .001  1.93 (0.71), p = .006   1.21 (0.12), p < .001 1.29 (0.29), p < .001 
   QS variance    2.34 (0.84), p = .005  1.88 (0.88), p = .03   1.17 (0.38), p = .002 1.08 (0.37), p = .003 
Covariance       
   I with LS  -0.05 (0.75), p = .95   0.03 (0.21), p = .56    -0.52 (0.46), p = .25 -0.44 (0.44), p = .32 
   I with QS   0.16 (0.36), p = .66   0.00 (0.30), p = .99     0.23 (0.20), p = .24 0.19 (0.19), p = .30 
   LS with QS -4.76 (1.73), p = .006  -3.84 (1.87), p = .04   -2.55 (0.82), p = .002 -2.36 (0.79), p = .003 
Time-invariant Covariates      
PTSD  I    0.03 (0.02), p = .25    0.04 (0.02), p = .09 
Intervention  I   -0.32 (0.27), p = .25    -0.23 (0.28), p = .41 
PTSD by Intervention  I    0.03 (0.03), p = .36    0.01 (0.03), p = .73 
Anxiety  I    0.03 (0.03), p = .41   0.07 (0.03), p = .03 





Table 3.4 (continued) Unconditional and Conditional Latent Growth Curve Model Estimates for the Effect of Baseline PTSD and 
Intervention Condition on Injection Drug and Sexual Risk Behavior 
 Injection Drug Risk Behavior  Sexual Risk Behavior 
 Unconditional LGCM  Conditional LGCM  Unconditional LGCM Conditional LGCM  
Time-invariant Covariates      
PTSD  LS    0.11 (0.10), p = .25    0.07 (0.06), p = .25 
Intervention  LS    0.87 (1.25), p = .49    0.76 (0.76), p = .31 
PTSD by Intervention  LS  -0.09 (0.14), p = .49   -0.15 (0.09), p = .08 
Anxiety  LS  -0.06 (0.13), p = .67    -0.25 (0.09), p = .003 
Depression  LS   0.06 (0.17), p = .75    0.21 (0.11), p = .06 
PTSD  QS  -0.07 (0.05), p = .18   -0.04 (0.03), p = .24 
Intervention  QS  -0.26 (0.63), p = .68   -0.19 (0.35), p = .60 
PTSD by Intervention  QS   0.04 (0.07), p = .53    0.05 (0.04), p = .21 
Anxiety  QS   0.05 (0.06), p = .46      0.13 (0.04), p = .002 
Depression  QS  -0.04 (0.09), p = .64   -0.11 (0.05), p = .04 







3.5 Deviance Tests for Unconditional and Conditional PTSD Models 
 -2LL, FP  χ2(df), p 
Slope   
Linear  -3409.39, 26  
Time-invariant covariates   
Intervention condition -3406.13, 28        3.26 (2), p = .20 
HCV seropositive status -3619.65, 30      210.26 (4), p < .001 
Time-varying covariates   
Anxiety and depression -7495.06, 71 4085.67 (54), p < .001 
Incarceration -3764.07, 37  354.68 (11), p < .001 
Interpersonal violence -3581.60, 37 172.21 (11), p < .001 
Note: -2LL = loglikelihood; FP = free parameters; df = degrees of freedom. Nested model 
comparisons (chi-square deviance tests) were used to test fit of each time-invariant and time-





Figure 3.1 Measurement Model for Latent PTSD Symptoms at Baseline, Month 6, and 
Month 12  
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Figure 3.3. Probability of Injection Drug Risk Behavior from Pre-incarceration to 
Community Release by Intervention Condition  
 
Note: The time-invariant covariates in this model include PTSD, anxiety and depression, 







































Figure 3.4. Probability of Sexual Risk Behavior from Pre-incarceration to Community 
Release by Intervention Condition  
 
Note: The time-invariant covariates in this model include PTSD, anxiety and depression, 
































Figure 3.5. Probability of Sexual Risk Behavior from Pre-incarceration to Community 
Release by +/-1 Standard Deviation in Anxiety Symptoms 
 
 
Note: The time-invariant covariates in this model include PTSD, anxiety and depression, 
































Figure 3.6. Probability of Sexual Risk Behavior from Pre-incarceration to Community 
Release by +/-1 Standard Deviation in Depressive Symptoms 
 
 
Note: The time-invariant covariates in this model include PTSD, anxiety and depression, 

































































CHAPTER 4. DISCUSSION 
Rural Appalachian women with substance use histories are a unique and particularly 
vulnerable group in need of targeted interventions aimed at reducing the spread of 
HCV/HIV. Symptoms of PTSD affect a large proportion of justice-involved rural women 
and may interfere with current efforts to reduce HCV/HIV risk behaviors (Staton et al., 
2017, 2018b; Weir et al., 2009). Thus, the purpose of this study was to examine HCV/HIV 
risk-reduction interventions administered to incarcerated women from rural Appalachia 
through a trauma-informed perspective (Facer-Irwin et al., 2019; Levenson & Willis, 2019; 
SAMHSA, 2014).  
4.1 Discussion of Primary Study Aims   
 The first aim of this study evaluated to what extent PTSD symptoms before and during 
incarceration predicted HCV/HIV risk behavior following community re-entry. Overall, 
women’s propensity to engage in injection drug and sexual risk behavior decreased after 
being released from jail, and their rate of change slowed across time. Additionally, women 
within the sample differed in their propensity to engage in HCV/HIV risk behavior before 
incarceration, and they displayed heterogeneous trajectories of risk behavior following 
community re-entry, supporting efforts to identify predictors of how risk behavior differs 
across incarcerated women. Consistent with and extending upon prior research conducted 
with women enrolled in the WISH study (Staton et al., 2018b), change in HCV/HIV risk 
behavior across the re-entry period (i.e., at months 3, 6, and 12) did not differ by 
intervention condition. Other studies have also found similar levels of risk reduction among 
substance users when comparing the effectiveness of HIV-Ed to enhanced interventions 
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involving additional counseling or culturally-informed content (Booth et al., 1998; Dushay 
et al., 2001). Both the HIV+MI and HIV-Ed interventions are feasible for use in jails. A 
single session of psychoeducation may be an efficient and cost-effective way to reduce 
HCV/HIV risk behaviors among rural Appalachian justice-involved women.  
 Although prior cross-sectional research suggests higher PTSD symptoms are 
associated with greater engagement in HCV/HIV risk behaviors among IV-exposed 
individuals (Cavanaugh et al., 2010; Plotzker et al., 2007), our findings indicate PTSD 
symptom severity leading up to and during incarceration was not associated with women’s 
change in injection drug or sexual risk behavior post-release from jail (Hypothesis 1a). 
Additionally, the interaction between baseline PTSD symptoms and intervention condition 
was not significant (Hypothesis 1b); having higher PTSD symptoms in the year before the 
baseline assessment was not associated with differences in how women responded to the 
HIV+MI or HIV-Ed interventions despite there being significant variability in their rate of 
change in HCV/HIV risk behavior during re-entry. Past research indicates individuals with 
PTSD have poorer outcomes in substance use treatment (Kubiak, 2004; Read et al., 2004) 
and benefit from enhanced monitoring while undergoing medical services for infectious 
diseases (Delahanty et al., 2004; Loftis et al., 2006). Yet, our results suggest PTSD 
symptoms leading up to and during incarceration may not influence the effectiveness of 
brief HCV/HIV risk reduction interventions administered to IV-exposed women in rural 
Appalachian jails.  
  The second aim of this study examined to what extent reductions in PTSD 
symptom severity following community re-entry predicted subsequent reductions in 
HCV/HIV risk behavior. PTSD symptoms decreased overall from baseline to community 
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re-entry, but women’s change in PTSD symptoms did not differ statistically based on 
which risk reduction intervention they received, although the association approached 
significance (p = .052). PTSD symptoms trended toward decreasing more during re-entry 
for women in the HIV+MI condition compared to women who received HIV-Ed. Past 
research supports the use of motivational interviewing to attenuate risk for developing 
PTSD following traumatic injury (Zatzick et al., 2004) and to enhance trauma-focused 
treatment outcomes and potentially reduce PTSD symptoms among veterans (Battaglia et 
al., 2016; Randall & McNeil, 2017). Although the present study’s findings did not 
corroborate our prediction for Hypothesis 2a, the results provide preliminary support 
suggesting further research should be conducted to specifically examine whether 
HCV/HIV risk-reduction interventions that include a motivational interviewing component 
may offer more promise at reducing PTSD symptoms than standard psychoeducational 
interventions for IV-exposed incarcerated women. However, this finding should be 
interpreted with caution since women in the HIV+MI condition started the study with more 
severe PTSD symptoms than women in the HIV-Ed condition, indicating randomization 
failed to yield equivalent groups at baseline on this variable. It is unclear whether the 
trending effect of intervention condition on post-incarceration PTSD symptoms was due to 
differences in intervention effectiveness or because women with higher PTSD severity at 
baseline experienced greater symptom improvements during re-entry. We did not conduct 
a sensitivity analysis for Aim 2, and it is possible the analytic methods we employed were 
underpowered to assess the effect of intervention condition on change in PTSD symptoms 
over the re-entry period. Future studies should ideally be designed to include sample sizes 
that provide enough power to detect small but potentially meaningful effects of 
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intervention condition and allow for robust comparisons among IV-exposed incarcerated 
women with high, low, and absent PTSD symptoms.  
 Our results also failed to demonstrate that reductions in PTSD from baseline to month 
6 would prospectively predict lower engagement in HCV/HIV risk behavior (Hypothesis 
2b). Past research indicates individuals with PTSD often self-medicate their symptoms by 
using substances or taking sexual risks (McCauley et al., 2012; Weiss et al., 2013). The 
self-medication hypothesis informed our prediction that decreases in PTSD would predict 
subsequent lower rates of HCV/HIV risk behavior since these behaviors may be 
inextricably linked with women’s ability to cope with trauma-related distress. However, 
change in PTSD post-release was not associated with subsequent HCV/HIV risk behavior, 
suggesting that patterns of change in PTSD symptoms and HCV/HIV risk behavior may 
unfold separately across the re-entry period for IV-exposed women. Women’s self-
medication of trauma-related symptoms may play a role during initiation or initial 
exacerbation of substance use and sexual risk-taking, whereas other processes may be more 
relevant when these behavioral patterns are well established (Berenz et al., 2019). For 
example, symptoms of physiological withdrawal or dependence may be more likely to 
maintain or promote injection drug risk behavior than self-medicating when trauma 
reminders arise for IV-exposed women with long histories of substance use. Sexual risk-
taking may serve as a way for vulnerable women to earn financial support, obtain 
substances, or to maintain safety in their sexual relationships (Mittal et al., 2013; Noska et 
al., 2016; Teitelman et al., 2008), despite past research suggesting these behaviors may 
also self-medicate trauma-related distress (Weiss et al., 2013). This study provides a 
snapshot of rural women’s trajectories prior to and following periods of incarceration. 
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Future research should include additional assessments before, during, and following 
periods of incarceration to better understand how patterns of PTSD and HCV/HIV risk 
behavior unfold as women interact with the justice system.   
 Null findings for the primary aims may be a function of the unique sample and methods 
included in this study, which were not initially designed to test the research questions 
herein. The face-to-face interview used to evaluate psychiatric symptoms—the GAIN—
was originally developed for substance use treatment providers to efficiently evaluate 
mental health and substance use problems to inform treatment placement and planning 
(Dennis et al., 2008), and was appropriate for the needs of the parent study. However, the 
GAIN does not comprehensively evaluate psychiatric disorders per criteria defined in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM; APA, 2013). To measure 
PTSD symptomology, The GAIN TSS includes 12 items that assess several important 
aspects of responses to “past events”, including nightmares and sleep problems, emotional 
arousal and numbing, risk-taking and urges, anger and irritability, feelings of disconnection 
from others, and self-blame. However, these items do not directly map on to the PTSD 
symptom criteria defined in the DSM. More specifically, the GAIN TSS does not include 
an assessment of trauma-related avoidance, memory and concentration problems, 
exaggerated negative beliefs about other people or the world, and hypervigilance or startle 
responses. Additionally, the GAIN TSS items are not anchored to a specific traumatic event 
(or events) that involved exposure to actual or threatened death, serious injury, or sexual 
violence (i.e., satisfy the definition of a Criterion A trauma in the DSM). Thus, the GAIN 
TSS may not comprehensively capture IV-exposed women’s PTSD symptomology as they 
transition in to and out of periods of incarceration; instead, this measure may reflect general 
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distress in response to a range of significant life stressors. Future research could improve 
upon these methodological limitations by including a measure that captures the frequency 
and severity of potentially traumatic events (e.g., the Life Events Checklist or the Trauma 
History Questionnaire; Hooper et al., 2011; Weathers et al., 2013), as well as a clinician-
administered or self-report assessment of PTSD symptoms that better reflect DSM-5 
diagnostic criteria (e.g., the Clinician-Administered PTSD Scale or the PTSD Checklist for 
DSM-5; Blevins et al., 2015; Weathers et al., 2018). 
 Another factor to consider is the distribution of baseline PTSD symptoms in the present 
sample of 320 IV-exposed women, who reflect a subset of all women enrolled in the WISH 
study (N = 400). Most women met criteria for “high traumatic stress” or possible PTSD 
(69.7%; >5 on the GAIN TSS) at the first assessment. However, PTSD symptom scores at 
baseline were bimodally distributed such that nearly half of women either reported 0 
(25.0%) or all twelve symptoms (23.4%). Additionally, very few IV-exposed women had 
a score between 1-4 on the GAIN TSS (5.4%). We purposefully selected IV-exposed 
women to be included in the present analyses given the association between victimization 
and HCV/HIV risk behavior (Mittal et al., 2013; Teitelman et al., 2008; Wagner et al., 
2009). Extending the sample to include women with other forms of trauma exposure may 
yield a distribution of PTSD that better reflects the spectrum of symptom severity.  
 Also important to note, the time frame in which PTSD symptoms were assessed may 
have been too broad to capture women’s responses to traumatic events and how they relate 
to or predict HCV/HIV risk behavior.  Women were asked about their PTSD symptoms in 
the 12 months leading up to the baseline assessment or since the last interview at the month 
6 and 12 follow-ups. It is possible that the spacing between PTSD assessments may account 
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for the lack of associations between PTSD symptom severity scores at baseline and follow-
ups. An alternative possibility is that women’s PTSD symptoms may have been 
exacerbated leading up to and during incarceration. Their change in PTSD during re-entry 
may represent a return to normative levels, indicating that PTSD symptoms during 
incarceration may not be reflective of women’s experiences of PTSD during re-entry. 
Longitudinal studies are needed that include assessments of PTSD symptoms at multiple 
time points prior to, during, and following periods of incarceration to understand patterns 
of change in PTSD symptoms and how these patterns relate to HCV/HIV risk behavior 
among IV-exposed justice-involved rural women. Additionally, future research could 
expand upon the current study by comparing the trajectories of PTSD and HCV/HIV risk 
behavior among IV-exposed rural women with histories of substance use and sexual risk-
taking who do and do not undergo periods of incarceration to understand the role that being 
in jail plays on the association between PTSD and HCV/HIV risk behavior.  
4.2 Exploratory Findings 
 In contrast with the null findings for PTSD symptoms on HCV/HIV risk behavior, 
higher levels of general anxiety leading up to and during incarceration were correlated with 
a higher propensity to have engaged in sexual risk behavior before incarceration and 
predicted a steeper decrease in sexual risk behavior across the re-entry period. Moreover, 
women with higher anxiety symptom severity at baseline experienced a more rapid 
decrease in sexual risk behavior soon after release from jail, whereas sexual risk behavior 
declined more steadily across the re-entry period among those with lower anxiety symptom 
severity. The opposite pattern was found for depression: women with lower depressive 
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symptoms at baseline experienced a steeper decrease in sexual risk behavior soon after 
release from jail, and post-incarceration sexual risk-taking declined more steadily for those 
with higher depressive symptoms. For women with higher anxiety or lower depressive 
symptoms, sexual risk behavior initially decreased from baseline to month 6 and 
subsequently increased from month 6 to month 12, resulting in no effect of anxiety or 
depressive symptoms on sexual risk-taking at the last assessment. Notably, these results 
were specific to sexual risk behavior, as both anxiety and depressive symptoms at baseline 
were not associated with injection drug risk behavior.  
 Some prior studies report a positive association between sexual risk behavior and 
symptoms of anxiety or depression among women (Coyle et al., 2019; Pettes et al., 2015; 
Staton-Tindall et a., 2015a), whereas others report no association (Crepaz and Marks, 
2001). In the present study, baseline levels of anxiety, PTSD, and depression showed strong 
positive correlations indicating that general psychiatric distress was elevated leading up to 
or during incarceration. However, only anxiety was associated with IV-exposed women’s 
sexual risk-taking at baseline, and both anxiety and depression were related to sexual risk 
behavior post-release. Anxiety symptoms may have contributed to sexual risk behavior 
prior to incarceration (above and beyond PTSD and depression) and may have also led to 
greater decreases in sexual risk-taking during the early stages of community re-entry. 
Although this finding may seem counterintuitive, it is possible that anxiety symptoms 
impaired women’s judgment and facilitated impulsive sexual decisions before 
incarceration (Erez et al., 2014; Khan et al., 2009) and also prompted women to engage in 
safer sex practices post-incarceration out of concern, worry, or fear of future consequences 
related to their sexual behavior, particularly if said behavior was associated with the reason 
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for incarceration. Anxiety symptoms are generally considered to be future-oriented, 
whereas PTSD symptoms (as measured by the GAIN TSS) are characterized by to what 
extent individuals are bothered by past traumatic events. Thus, symptoms of anxiety—but 
not PTSD—may relate to change in sexual risk behavior since they promote concern about 
future events or consequences. Continued research is needed to characterize the nature of 
women’s anxiety symptoms since the measurement tool used to assess anxiety symptoms 
(The GAIN AFS) provides a broad assessment of multiple anxiety-related diagnostic 
categories, including generalized anxiety, panic, phobias, obsessions and compulsions, 
anger, and paranoia. It is possible that worrying or concern about the future, the possibility 
of being arrested again or contracting and transmitting infectious diseases, or about their 
own health or the health of their partners, may be protective (i.e., associated with reductions 
in sexual risk behaviors) or maladaptive (i.e., increases or has no association with sexual 
risk-taking). Additionally, future longitudinal research is needed to examine whether 
sexual risk behavior among women with low anxiety symptoms continues to decrease and 
whether women with high anxiety symptoms experience an increase in sexual risk-taking 
past the one-year mark of having re-entered into the community.  
 Given the unexpected association between anxiety and sexual risk behavior, we 
conducted an exploratory analysis and found that intervention condition did not lead to 
different associations between anxiety and post-release sexual risk behavior trajectories 
(see appendix). All study participants received psychoeducation on safe sex practices, 
which may have prompted women with higher anxiety symptoms to reflect on the 
consequences of their sexual behavior, facilitating a short-term decrease in post-release 
sexual risk-taking. However, as mentioned above, it is unclear whether the significant post-
 54 
release decrease in sexual risk-taking among all participants is due to being incarcerated, 
receiving an HCV/HIV risk reduction intervention, or a naturalistic pattern of behavior 
change over time. Our results suggest that psychiatric symptoms, and specifically anxiety 
and depression, may be more closely related to post-incarceration sexual risk behaviors 
than injection drug risk behaviors.  Women were enrolled in the study if they had a history 
of using substances and were (at least) in moderate need of a substance use intervention. 
Prevention and treatment strategies aimed at reducing sexual risk behaviors among 
vulnerable justice-involved women with substance use histories may benefit from 
integrating evidence-based strategies that address anxiety symptoms, whereas 
interventions for injection drug risk behavior may focus on addressing symptoms of 
addiction (e.g., tolerance, withdrawal, physiological dependence). Our results also 
highlight the need to explore alternative or additional interventions, such as anxiety-
focused treatments or booster sessions during re-entry, particularly for women with high 
anxiety symptoms before and during incarceration.  
4.3 Implications, Limitations, and Directions for Future Research  
 The present study’s findings have important implications for providing mental and 
behavioral healthcare to incarcerated rural Appalachian women with histories of substance 
use, sexual risk behavior, and IV. As described above, women’s overall engagement in 
HCV/HIV risk behavior and PTSD symptoms decreased following release from jail. 
However, the study design precludes our ability to state whether change in risk behavior 
and PTSD symptoms is due to the brief HCV/HIV risk reduction interventions women 
received or to periods of or release from incarceration. Despite the overall decrease in risk 
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behavior, many women engaged in at least one form of injection drug (18-24%) or sexual 
risk behavior (54-67%) after re-entering into the community. Additionally, 31-41% of 
women continued to meet criteria for possible PTSD (>5 symptoms on TSS) post-
incarceration, a rate that is substantially higher than estimates from the general U.S. 
population (10%; Mitchell et al., 2012). Rural Appalachian women who engage in 
HCV/HIV risk behaviors or experience PTSD symptoms post-release may benefit from 
psychosocial support or treatments beyond what was provided in the WISH study while in 
jail or following community re-entry.  
Establishing predictors of intervention response is an important area of research and 
can help providers make informed decisions regarding which intervention is appropriate at 
what dose and for whom. Some IV-exposed women may benefit from brief behavioral risk 
reduction interventions offered during incarceration, whereas others may require more 
intensive interventions, including evidence-based trauma-informed interventions or PTSD-
specific treatments. Trauma-informed interventions promote awareness of the impact 
trauma exposure has on the individual and typically include strength-based approaches that 
promote recovery, resilience, and overall wellness by teaching cognitive and behavioral 
skills. Several trauma-informed interventions have been successfully administered in jails 
and prisons and demonstrate reductions in PTSD symptoms, substance use, and sexual risk-
taking (Hien et al., 2010; see King, 2017 for a review). However, to the authors’ 
knowledge, the effectiveness of “gold standard” psychological treatments that specifically 
target PTSD symptoms has yet to be tested among currently incarcerated or imprisoned 
populations (Harner et al., 2015). One study examining the effect of a group-based PTSD-
specific treatment (e.g., Cognitive Processing Therapy) among imprisoned men and 
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women has recently completed data collection, and results are forthcoming (Koenigs, 
2019). PTSD-specific treatments require clinicians to receive specialized training and are 
typically offered over the course of 12-16 weeks (Lancaster et al., 2016). Although 
possible, these factors make the widespread implementation of PTSD-specific treatments 
in jail settings improbable due to the transient nature of the population and limited 
resources available. Important future directions are to identify who will benefit from brief 
behavioral interventions, who needs (or would prefer) additional or alternative trauma-
focused care, and when is the optimal time to administer the interventions.  
 Future research should investigate rural Appalachian women’s uptake of 
behavioral and medical healthcare after being released from jail. Past research by Dushay 
and colleagues (2001) suggests that although there was no difference in HCV/HIV risk 
reduction between the HIV-Ed and an enhanced culturally-informed intervention 
administered to substance users in the community, individuals who enrolled in substance 
use treatment services in the six months following the interventions demonstrated greater 
reductions in risk behavior at follow-up than those who did not. Women in the present 
sample were not seeking mental or behavioral health treatment when they enrolled in the 
study but were given a list of local health services in rural Appalachia as part of 
psychoeducation. Unlike treatment-seeking samples, women in the current study may have 
presented with varying levels of motivation to change their injection drug and sexual risk 
behaviors or engage in services during community re-entry. Examining the uptake of 
mental and behavioral health treatment after women are released from jail may help to 
elucidate factors that explain the variability in women’s propensity to engage in HCV/HIV 
risk behaviors during re-entry, especially considering the geographic barriers to health care 
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services and stigma against help-seeking that Appalachian women face. Other notable 
factors to consider are women’s perceptions of HCV/HIV risk behaviors, their ability to 
obtain stable housing and employment, as well as the quality of their social support 
networks and level of caretaking responsibilities following release from jail (Clone et al., 
2014; Staton-Tindall et al., 2015b; Visher & Bakken, 2014).   
 Although findings from this study are not generalizable to men, women of color, and 
individuals outside of rural Appalachia or without justice involvement, this study focuses 
on a population—justice-involved rural Appalachian women with IV histories—that is at 
risk for deleterious health consequences and, until recently, has not been a focus of 
HCV/HIV prevention efforts. Experiences of physical, sexual, and emotional abuse are 
ubiquitous among rural Appalachian women who use substances (Shannon et al., 2016; 
Staton et al., 2018b) and may be perceived by these women as normal or unavoidable. 
Since IV-exposed women may have a poorer perceived ability to negotiate safe injection 
and sex practices with their intimate partners (Mittal et al., 2013; Teitelman et al., 2008; 
Wagner et al., 2009), it is possible that women who transition back into relationships with 
partners that perpetrate IV may be at increased risk for HCV/HIV following release from 
jail. Designing strength-based HCV/HIV risk reduction interventions that explicitly target 
the cultural values of self-reliance and resiliency promoted by Appalachian communities 
(Helton & Keller, 2010) may foster women’s empowerment in their romantic relationships 
and increase their perceived ability to safely engage in HCV/HIV behaviors.  
 In addition to the aforementioned ways future research can expand upon the 
methodological limitations of the present study, several other improvements should be 
considered. First, PTSD symptoms were only measured at three time points, which 
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precluded our ability to model non-linear change, as well as to conduct a more nuanced 
analysis evaluating how reductions in PTSD symptoms predict reductions in HCV/HIV 
risk behavior following release from jail. Increasing the number of assessments could boost 
statistical power for advanced analyses modeling the parallel process of change in PTSD 
and HCV/HIV risk behavior over time (Little, 2013). Additionally, longitudinal studies 
with multiple assessments of PTSD symptoms prior to, during, and following periods of 
incarceration could elucidate patterns of change in PTSD symptoms among IV-exposed 
justice-involved rural women with substance use histories. Second, the interview used to 
assess PTSD, anxiety, and depression—the GAIN—was based on the fourth edition of the 
DSM but was not a formal diagnostic assessment. Future research evaluating psychiatric 
conditions among justice-involved women may consider using clinician-administered 
assessments or self-report measures that are based on criteria in the updated fifth edition of 
the DSM to increase diagnostic precision. However, increasing the number of assessments 
and including formal diagnostic measures should be carefully weighed against the added 
participant burden. Third, the present study did not have a control condition, which 
precludes our ability to draw definitive conclusions regarding the impact of brief HCV/HIV 
risk reduction interventions above and beyond periods of or release from incarceration. 
Additionally, we are not able to discern whether women in the sample benefited from 
HCV/HIV interventions specifically or whether they would have benefited from any 
intervention at all. Future research could explore to what extent periods of incarceration 
alone may facilitate changes in HCV/HIV risk behaviors, given that individuals in jail are 
often separated from environments where injection and sexual risk behaviors occur. 
However, excluding a control condition is a common practice when testing efficacious 
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interventions in real-world settings (Buchanan et al., 2007), given the ethical concerns for 
withholding interventions that may be beneficial to at-risk or vulnerable individuals.  
 
4.4 Conclusions  
  This study addresses a critical gap in efforts to reduce injection drug and sexual 
risk behavior among IV-exposed rural Appalachian women with substance use histories—
a uniquely vulnerable and disadvantaged population at high risk for deleterious health 
outcomes—by examining brief HCV/HIV interventions through a trauma-informed 
perspective. Our findings indicate PTSD symptoms were not associated with women’s 
change in injection drug or sexual risk behavior after community re-entry. Moreover, 
women’s change in HCV/HIV risk behavior after being released from jail did not differ 
based on whether they received brief psychoeducation or a motivational interviewing-
based intervention while incarcerated. PTSD symptoms trended toward decreasing more 
during re-entry for women who received a motivational-interviewing enhanced 
intervention compared to women who received psychoeducation alone, although this 
should be interpreted with caution. An unexpected finding was that anxiety and depressive 
symptoms prior to and during incarceration were associated with different trajectories of 
change in sexual, but not injection drug, risk behavior post-release. The results of this study 
add to a growing literature aimed at developing targeted prevention and intervention efforts 
for reducing HCV/HIV risk behaviors among justice-involved rural Appalachian women.   
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APPENDIX 
Supplemental Table. Conditional Latent Growth Curve Model Estimates for the Effect of 
Baseline Anxiety and Intervention Condition on Sexual Risk Behavior 
 Sexual Risk Behavior 
 Conditional LGCM  
Means and Variances   
   I mean  1.72 (0.25), p < .001 
   I variance  0.74 (0.25), p = .003 
   LS mean      -3.08 (0.63), p < .001 
   LS variance  5.40 (1.77), p = .002 
   QS mean 1.21 (0.29), p < .001 
   QS variance  1.09 (0.37), p = .003 
Covariance   
   I with LS -0.43 (0.44), p = .33 
   I with QS 0.19 (0.19), p = .30 
   LS with QS -2.40 (0.79), p = .002 
Time-invariant Covariates  
   PTSD  I    0.05 (0.02), p = .008 
   Intervention  I -0.36 (0.28), p = .19 
   Anxiety by Intervention  I  0.05 (0.04), p = .35 
   Anxiety  I  0.05 (0.04), p = .25 
   Depression  I -0.05 (0.04), p = .24 
   PTSD  LS -.003 (0.05), p = .95 
   Intervention  LS   025 (0.76), p = .74 
   Anxiety by Intervention  LS -0.11 (0.12), p = .35 
   Anxiety  LS -0.18 (0.11), p = .09 
   Depression  LS  0.20 (0.11), p = .08 
   PTSD  QS -0.01 (0.22), p = .67 
   Intervention  QS  0.02 (0.35), p = .97 
   Anxiety by Intervention  QS  0.03 (0.05), p = .56 
   Anxiety  QS   0.11 (0.05), p = .04 
   Depression  QS -0.10 (0.05), p = .05 
Note: I = intercept; LS = linear slope; QS = quadratic slope. Unstandardized estimates are 
shown with standard errors in parentheses.  
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